1. Home
  2. NEO vs ATRC Comparison

NEO vs ATRC Comparison

Compare NEO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$16.90

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo AtriCure Inc.

ATRC

AtriCure Inc.

N/A

Current Price

$58.90

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEO
ATRC
Founded
2001
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2008
2005

Fundamental Metrics

Financial Performance
Metric
NEO
ATRC
Price
$16.90
$58.90
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$23.40
★ $60.44
AVG Volume (30 Days)
★ 1.9M
741.7K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.74
EPS
N/A
★ 0.27
Revenue
N/A
★ $201,630,000.00
Revenue This Year
$11.12
$13.42
Revenue Next Year
$9.68
$12.24
P/E Ratio
★ N/A
$242.70
Revenue Growth
N/A
★ 15.40
52 Week Low
$7.07
$25.36
52 Week High
$20.15
$66.02

Technical Indicators

Market Signals
Indicator
NEO
ATRC
Relative Strength Index (RSI) 45.40 49.44
Support Level $15.73 $55.16
Resistance Level $17.19 $61.70
Average True Range (ATR) 0.86 2.80
MACD -0.01 -0.12
Stochastic Oscillator 29.78 27.84

Price Performance

Historical Comparison
NEO
ATRC

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: